Mannan-modified Ad5-PTEN treatment combined with docetaxel improves the therapeutic effect in H22 tumor-bearing mice

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5039-5049

  Liu, Zhongbing ^a   Li, Jinwei ^a   Li, Juan ^a   Huang, Juan ^a   Ke, Famin ^a   Qi, Qiaona ^a   Jiang, Xing ^a   Zhong, Zhirong ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus vector; Cancer gene therapy; Docetaxel; Mannan; PTEN gene

Indexed keywords

ADENOVIRUS VECTOR; DOCETAXEL; MANNAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MONOTHERAPY; MOUSE; NICK END LABELING; NONHUMAN; PTEN GENE; TUMOR VOLUME; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; GENETIC THERAPY; LIVER NEOPLASMS; MALE; MANNANS; MICE; NANOCAPSULES; PTEN PHOSPHOHYDROLASE; TAXOIDS; TRANSFECTION; TREATMENT OUTCOME;

ADENOVIRIDAE; MURINAE; MUS;

EID: 84870336827     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S34022     Document Type: Article

References (34)

1. Hatefi A, Cappello J, Ghandehari H. Adenoviral gene delivery to solid tumors by recombinant silk-elastin-like protein polymers. Pharm Res. 2007;24(4):773-779.
2. Yao XL, Nakagawa S, Gao JQ. Current targeting strategies for adenovirus vectors in cancer gene therapy. Curr Cancer Drug Targets. 2011; 11(7):810-825.
3. Yao X, Yoshioka Y, Morishige T, etal. Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy. Mol Ther. 2011;19(9):1619-1625.
4. Korokhov N, Mikheeva G, Krendelshchikov A, etal. Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge. J Virol. 2003;77(24):12931-12940.
5. Zeng Q, Han J, Zhao D, Gong T, Zhang Z, Sun X. Protection of adenovirus from neutralizing antibody by cationic PEG derivative ionically linked to adenovirus. Int J Nanomedicine. 2012;7:985-997.
6. Li J, Yen C, Liaw D, etal. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275(5308):1943-1947.
7. Steck PA, Pershouse MA, Jasser SA, etal. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997;15(4):356-362.
8. Zhang C, Kang C, Wang P, etal. MicroRNA-221 and-222 regulate radiation sensitivity by targeting the PTEN pathway. Int J Radiat Oncol Biol Phys. 2011;80(1):240-248.
9. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis. 2007;27(1):55-76.
10. Weng LP, Brown JL, Eng C. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet. 2001;10(6):599-604.
11. Weng L, Brown J, Eng C. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and-independent pathways. Hum Mol Genet. 2001;10(3):237-242.
12. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science. 1998;280(5369):1614-1617.
13. Dahia PL. PTEN, a unique tumor suppressor gene. Endocr Relat Cancer. 2000;7(2):115-129.
14. Li DM, Sun H. PTEN/MMAC1/TEP1suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A. 1998;95(26):15406-15411.
15. Furnari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1growth arrest in glioma cells. Cancer Res. 1998;58(22):5002-5008.
16. Davies MA, Lu Y, Sano T, etal. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res. 1998;58(23):5285-5290.
17. Sawai H, Yasuda A, Ochi N, etal. Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol. 2008;8:56.
18. Hsu CP, Kao TY, Chang WL, Nieh S, Wang HL, Chung YC. Clinical significance of tumor suppressor PTEN in colorectal carcinoma. Eur J Surg Oncol. 2011;37(2):140-147.
19. Pappas G, Zumstein LA, Munshi A, Hobbs M, Meyn RE. Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity. Cancer Gene Ther. 2007;14(6):543-549.
20. Steelman LS, Navolanic PM, Sokolosky ML, etal. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors. Oncogene. 2008;27(29):4086-4095.
21. Mellinghoff IK, Cloughesy TF, Mischel PS. PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res. 2007;13(2 Pt 1):378-381.
22. Magnusson S, Berg T. Extremely rapid endocytosis mediated by the mannose receptor of sinusoidal endothelial rat liver cells. Biochem J. 1989;257(3):651-656.
23. Yeeprae W, Kawakami S, Yamashita F, Hashida M. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O/W emulsions by macrophages. J Control Release. 2006;114(2): 193-201.
24. Magnusson S, Berg T. Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells. Biochem J. 1993;291(Pt 3):749-755.
25. Kawakami S, Sato A, Nishikawa M, Yamashita F, Hashida M. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. 2000;7(4):292-299.
26. Apostolopoulos V, Pietersz GA, Loveland BE, Sandrin MS, McKenzie IF. Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses. Proc Natl Acad Sci U S A. 1995;92(22):10128-10132.
27. Liu Q, Li R, Zhu Z, etal. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Int J Pharm. 2012;430(1-2):350-358.
28. Lin C, Wei W, Zhang J, Liu S, Liu Y, Zheng D. Formyl peptide receptor-like 1mediated endogenous TRAIL gene expression with tumoricidal activity. Mol Cancer Ther. 2007;6(10):2618-2625.
29. Stewart AL, Mhashilkar AM, Yang XH, etal. PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells. Mol Med. 2002;8(8):451-461.
30. Liu Q, Li RT, Qian HQ, etal. Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles. Int J Nanomedicine. 2012;7:281-295.
31. Zhong Z, Wan Y, Han J, Shi S, Zhang Z, Sun X. Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes. Int J Nanomedicine. 2011;6: 1083-1093.
32. Zhong Z, Shi SJ, Han JF, Zhong ZR, Sun X. Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackie-adenovirus receptor deficient cells. Mol Pharm. 2010;7(1):105-115.
33. Zhong Z, Wan Y, Shi S, Han J, Zhang Z, Sun X. Co-delivery of adenovirus and carmustine by anionic liposomes with synergistic anti-tumor effects. Pharm Res. 2012;29(1):145-157.
34. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A. 1999;96(8):4240-4245.